<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-23T01:35:10+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>成立仅3个月，海森21亿接盘武田剥离资产，背后出资的大佬是谁？</title>
    <updated>2020-12-22T23:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/t-ibxnwV7GshqhcW5LvoCg</id>
    <link href="https://mp.weixin.qq.com/s/t-ibxnwV7GshqhcW5LvoCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>蔡东晨：不创新就意味着死！二甲双胍1.54分/片，全国都给你也不足以养活你！</title>
    <updated>2020-12-22T23:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/0m2sIzbphIdw8ERRKAB9UA</id>
    <link href="https://mp.weixin.qq.com/s/0m2sIzbphIdw8ERRKAB9UA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投资人视角|医保谈判靴子落地，二级市场反应积极</title>
    <updated>2020-12-22T23:18:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/cFvBDaogVfAolBeocqZBBQ</id>
    <link href="https://mp.weixin.qq.com/s/cFvBDaogVfAolBeocqZBBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>成立两年即上市，在眼科赛道，看这家“新生牛犊”如何冲击第一？底气是什么？</title>
    <updated>2020-12-21T21:47:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/POHcw_KQtNNllPB9gsynlg</id>
    <link href="https://mp.weixin.qq.com/s/POHcw_KQtNNllPB9gsynlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天药混改，上药大股东入局，图啥？</title>
    <updated>2020-12-21T21:47:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/haB9HYGzV86GVpJ2n7XQnw</id>
    <link href="https://mp.weixin.qq.com/s/haB9HYGzV86GVpJ2n7XQnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪ATG-010 (XPOVIO)由FDA提前三个月批准二线骨髓瘤方案，并已提交新加坡和澳大利亚XPOVIO三种适应症上市申请</title>
    <updated>2020-12-21T21:47:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/miusKaxOsPHIAFdjxxN1nA</id>
    <link href="https://mp.weixin.qq.com/s/miusKaxOsPHIAFdjxxN1nA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药零售迎十年黄金期，国大药房、大参林、老百姓5大营收进击5000亿！</title>
    <updated>2020-12-20T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/aV4j6Wk2PmtZqgDBbT71FA</id>
    <link href="https://mp.weixin.qq.com/s/aV4j6Wk2PmtZqgDBbT71FA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>冲击新目标，65岁中国中药再出发！</title>
    <updated>2020-12-20T19:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/j8V2elxSgmYQux9bnMQ1tg</id>
    <link href="https://mp.weixin.qq.com/s/j8V2elxSgmYQux9bnMQ1tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>我就想问，医药代表能不能做一辈子？多家MNC代表灵魂发问</title>
    <updated>2020-12-19T22:23:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/rg-n1pARFcyJtsj4GsyG2w</id>
    <link href="https://mp.weixin.qq.com/s/rg-n1pARFcyJtsj4GsyG2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投资人视角|单日终止5家，A股IPO风向急转</title>
    <updated>2020-12-19T22:23:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Z74eaPHnCfeHmwIEMEfp1w</id>
    <link href="https://mp.weixin.qq.com/s/Z74eaPHnCfeHmwIEMEfp1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>构建人类健康命运共同体，全球中医药人在行动</title>
    <updated>2020-12-19T22:23:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/104BVXC25QOevTkJmTq_Ew</id>
    <link href="https://mp.weixin.qq.com/s/104BVXC25QOevTkJmTq_Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“这次没谈成，回去只能把公司卖掉了！”遭遇腰斩降价的药企，这个冬天，难了</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/QBaIVJAqhefCMTaZIXT7FA</id>
    <link href="https://mp.weixin.qq.com/s/QBaIVJAqhefCMTaZIXT7FA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总点击50万的文章背后，我们看到了患者的无奈和药价谈判的真实意义！</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/YE3cof0QK8KTCr52NQGpdA</id>
    <link href="https://mp.weixin.qq.com/s/YE3cof0QK8KTCr52NQGpdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020全球最大生物医药IPO！荣昌生物共募资5.9亿美元</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/AaWfrdkyhbEMaLCokyQBvA</id>
    <link href="https://mp.weixin.qq.com/s/AaWfrdkyhbEMaLCokyQBvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>腾盛博药研发战略取得重大进展</title>
    <updated>2020-12-18T21:11:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/OweY6BKAoZPFVVij7jH07Q</id>
    <link href="https://mp.weixin.qq.com/s/OweY6BKAoZPFVVij7jH07Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞冲击6000亿！本土豪门、生物新贵、MNC的PD-1“权力游戏”,高潮才刚开始……</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/E-yeq50YnOQORbUs7fx0ew</id>
    <link href="https://mp.weixin.qq.com/s/E-yeq50YnOQORbUs7fx0ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首个1类新药获批，这家药企正式步入创新药时代</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/QE8ZLWUV5lzNMzQ_AvpuEQ</id>
    <link href="https://mp.weixin.qq.com/s/QE8ZLWUV5lzNMzQ_AvpuEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百洋医药商业化平台进阶，与安斯泰来达成进口新药合作意向</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/Doo1jZG3IqlmLg-6ryvqzg</id>
    <link href="https://mp.weixin.qq.com/s/Doo1jZG3IqlmLg-6ryvqzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>支架集采后该怎么办？如何保证用量？医保局规定来了！</title>
    <updated>2020-12-17T22:54:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/XMvz2udbE2QbXN23t7QUVg</id>
    <link href="https://mp.weixin.qq.com/s/XMvz2udbE2QbXN23t7QUVg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医保谈判DAY3：恒瑞PD-1大降超80%，4个适应证全进医保，K药、O药没进？</title>
    <updated>2020-12-16T19:24:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/-0RqOiY_AGcnTD7q89WulQ</id>
    <link href="https://mp.weixin.qq.com/s/-0RqOiY_AGcnTD7q89WulQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>